🇺🇸 Yanimo in United States

13 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 13

Most-reported reactions

1. Chronic Obstructive Pulmonary Disease — 2 reports (15.38%)
2. Dyspnoea — 2 reports (15.38%)
3. Stomatitis — 2 reports (15.38%)
4. Abdominal Discomfort — 1 report (7.69%)
5. Asthenia — 1 report (7.69%)
6. Bladder Tamponade — 1 report (7.69%)
7. Bradycardia — 1 report (7.69%)
8. Cardiac Failure — 1 report (7.69%)
9. Death — 1 report (7.69%)
10. Decreased Appetite — 1 report (7.69%)

Source database →

Frequently asked questions

Is Yanimo approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Yanimo in United States?

Fundacio Privada Mon Clinic Barcelona is the originator. The local marketing authorisation holder may differ — check the official source linked above.